Actuate Therapeutics, Inc.
ACTU
$1.32
-$0.05-3.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.43M | 8.13M | 13.16M | 16.92M | 6.49M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 322.10K | 385.40K | 484.00K | 519.20K | 195.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.75M | 8.52M | 13.64M | 17.44M | 6.69M |
|
|
|||||
| Total Current Assets | 4.75M | 8.52M | 13.64M | 17.44M | 6.69M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 451.40K | 391.80K | 392.50K | 269.90K | 280.30K |
| Total Assets | 5.20M | 8.91M | 14.04M | 17.71M | 6.97M |
|
|
|||||
| Total Accounts Payable | 1.08M | 1.20M | 1.52M | 1.25M | 3.17M |
| Total Accrued Expenses | 2.73M | 3.52M | 4.18M | 5.13M | 6.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.81M | 4.72M | 5.71M | 6.37M | 9.20M |
|
|
|||||
| Total Current Liabilities | 3.81M | 4.72M | 5.71M | 6.37M | 9.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 421.90K |
| Total Liabilities | 4.21M | 5.13M | 6.11M | 6.78M | 9.62M |
|
|
|||||
| Common Stock & APIC | 166.09M | 164.02M | 162.53M | 160.99M | 141.99M |
| Retained Earnings | -165.10M | -160.23M | -154.61M | -150.05M | -144.65M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 989.20K | 3.78M | 7.92M | 10.94M | -2.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 989.20K | 3.78M | 7.92M | 10.94M | -2.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 989.20K | 3.78M | 7.92M | 10.94M | -2.65M |
|
|
|||||